PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?

by Franzese, Elisena, Diana, Anna, Centonze, Sara, Pignata, Sandro, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Published in Front Oncol (2020)

Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes

by Diana, Anna, Carlino, Francesca, Franzese, Elisena, Oikonomidou, Olga, Criscitiello, Carmen, De Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Published in Cancers (Basel) (2020)

Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy

by Diana, Anna, Carlino, Francesca, Giunta, Emilio Francesco, Franzese, Elisena, Guerrera, Luigi Pio, Di Lauro, Vincenzo, Ciardiello, Fortunato, Daniele, Bruno, Orditura, Michele
Published in Curr Treat Options Oncol (2021)

Genomic Profile and BRCA-1 Promoter Methylation Status in BRCA Mutated Ovarian Cancer: New Insights in Predictive Biomarkers of Olaparib Response

by Franzese, Elisena, Centonze, Sara, Diana, Anna, Lombardi, Angela, Carlino, Francesca, Guerrera, Luigi Pio, De Vita, Ferdinando, Caraglia, Michele, Pignata, Sandro, Ciardiello, Fortunato, Orditura, Michele
Published in Front Oncol (2019)

Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions

by Montella, Liliana, Altucci, Lucia, Sarno, Federica, Buonerba, Carlo, De Simone, Stefano, Facchini, Bianca Arianna, Franzese, Elisena, De Vita, Ferdinando, Tafuto, Salvatore, Berretta, Massimiliano, Facchini, Gaetano
Published in Cancers (Basel) (2021)

Phosphatidylinositol 3-kinase (PI3Kα)/AKT axis blockade with taselisib or ipatasertib enhances the efficacy of anti-microtubule drugs in human breast cancer cells

by Morgillo, Floriana, Della Corte, Carminia Maria, Diana, Anna, Mauro, Concetta di, Ciaramella, Vincenza, Barra, Giusi, Belli, Valentina, Franzese, Elisena, Bianco, Roberto, Maiello, Evaristo, de Vita, Ferdinando, Ciardiello, Fortunato, Orditura, Michele
Published in Oncotarget (2017)

Enhanced Antitumor Effect of Trastuzumab and Duligotuzumab or Ipatasertib Combination in HER-2 Positive Gastric Cancer Cells

by Laterza, Maria Maddalena, Ciaramella, Vincenza, Facchini, Bianca Arianna, Franzese, Elisena, Liguori, Carmela, De Falco, Stefano, Coppola, Paola, Pompella, Luca, Tirino, Giuseppe, Berretta, Massimiliano, Montella, Liliana, Facchini, Gaetano, Ciardiello, Fortunato, de Vita, Ferdinando
Published in Cancers (Basel) (2021)

The use of (68)Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities

by Franzese, Elisena, Falco, Stefano De, Laterza, Maria Maddalena, Montella, Liliana, Facchini, Sergio, Liguori, Carmela, Coppola, Paola, Diessa, Ylenia, Berretta, Massimiliano, Pisconti, Salvatore, Trama, Francesco, Ferro, Matteo, Crocetto, Felice, Fasano, Morena, Buonerba, Carlo, Facchini, Gaetano
Published in Future Sci OA (2021)

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study

by Farolfi, Alberto, Scarpi, Emanuela, Greco, Filippo, Bergamini, Alice, Longo, Lucia, Pignata, Sandro, Casanova, Claudia, Cormio, Gennaro, Bologna, Alessandra, Orditura, Michele, Zavallone, Laura, Attademo, Laura, Gallà, Valentina, Franzese, Elisena, Pigozzi, Eva, Loizzi, Vera, Giorda, Giorgio, Giardina, Donatella, Cioffi, Raffaella, De Giorgi, Ugo
Published in Sci Rep (2020)